Cyclin Dependent Kinase Inactivation
Cyclin Dependent Kinase Inactivation - Related Videos
12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
0 Views •
Cited by 10 •
2018
Cyclin-dependent kinase 1 (Cdk1) is activated in the G2 phase of the cell cycle and regulates many cellular pathways. Here, we present a protocol for an in vitro kinase assay with Cdk1, which allows the identification of Cdk1-specific phosphorylation sites for establishing cellular targets of this important kinase.
01:58
X-Inactivation
0 Views •
2019
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results. Instead, in order to avoid this potential issue, female mammalian cells inactivate nearly all the genes in one of their X chromosomes during early embryonic development. In the nuclear envelope surrounding the cell nucleus, the inactivated X chromosome...
01:58
X-inactivation
0 Views •
2021
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results. Instead, in order to avoid this potential issue, female mammalian cells inactivate nearly all the genes in one of their X chromosomes during early embryonic development. In the nuclear envelope surrounding the cell nucleus, the inactivated X chromosome...
01:25
cAMP-dependent Protein Kinase Pathways
0 Views •
2023
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
02:54
Protein Kinases and Phosphatases
0 Views •
2020
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven. Protein kinases Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
FAQs
Removing an activating cyclin reduces the stimulation that a CDK requires for kinase activity. This provides a reversible way to limit CDK-driven cell-cycle progression and helps coordinate transitions between phases. Because cyclin removal is one of several control mechanisms, cells can combine it with inhibitory phosphorylation or CDK inhibitor proteins to strengthen or fine-tune cell-cycle restraint.
Inhibitory phosphorylation regulates CDK activity by adding phosphate groups that suppress the kinase. CDK inhibitor proteins act through direct binding, blocking kinase activity and access to substrates. These mechanisms interfere with CDK function in different ways, allowing cells to control both the catalytic activity of the enzyme and its ability to interact with cellular targets.
The timing of CDK inactivation helps prevent inappropriate movement through the cell cycle. By restraining kinase activity when progression should stop or change, cells can better coordinate phase transitions and reduce conditions associated with disrupted cell-cycle control. This coordination supports genome stability, whereas inadequate regulation can contribute to abnormal proliferation.
Cell-cycle arrest can be supported by reducing CDK activity through cyclin removal, inhibitory phosphorylation, or CDK inhibitor proteins. These mechanisms prevent continued progression when cells receive stress or differentiation signals. Studying which form of control is engaged helps connect external or developmental cues with the internal regulation that pauses cell-cycle progression.
Cancer research examines CDK inactivation because disrupted cell-cycle control can promote uncontrolled proliferation. Understanding how cells normally restrict CDK activity provides a framework for investigating how that restraint fails in disease. It also helps researchers study CDK pathways as potential points for targeted modulation while relating pathway behavior to abnormal growth.
CDK inactivation connects cell-cycle regulation with differentiation, development, and responses to treatment. Researchers can use this relationship to examine how changes in CDK pathway activity influence whether cells continue dividing, pause, or respond to developmental signals. Targeted modulation of these pathways can therefore inform studies of therapeutic response without treating cell-cycle activity as an isolated process.